ResMed (RMD) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Adjusted EPS
- $2.95
- Estimate
- $2.89
- Surprise
- +2.0%
- Score today
- 5.7/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
ResMed (RMD) beat the $2.89 estimate with adjusted EPS of $2.95 — a modest 2.0% upside surprise.
Where TrendMatrix's rating stands now
TrendMatrix currently rates RMD Hold at 5.7/10; no pre/post engine snapshot brackets this report.
4 of the last 4 quarters beat the estimate; this quarter's +2.0% surprise compares with a +2.3% four-quarter average. Next scheduled report: 2026-10-29.
What supports the rating
- V7 flight-to-quality bonus: +0.5 (Q=8.8 in RISK_OFF)
- Sector modifier (Healthcare): +0.5
What argues against it
- Concentration risk — Geographic: manufacturing outside the U.S.
- Analyst target reached - limited upside remaining
- Weak growth
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $222.30
- Entry target
- $205.80
- Price target
- $222.81
- Stop
- $194.46
- Upside to target
- +0.2%
- Reward-to-risk
- 0.0:1
The stock trades at 21.3× trailing but 16.8× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-09-24 — shown for context, not personalized investment advice.
RMD at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Instruments & Supplies
- Market cap
- $32.02B
- P/E (fwd)
- 16.8
- P/E (ttm)
- 21.3
- 52-week range
- $180.27–$284.87
- Off 52-week high
- 22.0%
- RSI (14)
- 37
- Volume vs avg
- 1.03×
- Score today
- 5.7/10